A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

NCT01169090 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

620

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: SK-0403
DRUG: Placebo
DRUG: Sitagliptin

Sponsor

Kowa Research Institute, Inc.